MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK.
Centre for Medicines Discovery, University of Oxford, Oxford, UK.
Cell Death Dis. 2021 Feb 8;12(2):165. doi: 10.1038/s41419-021-03437-w.
The human MRE11/RAD50/NBS1 (MRN) complex plays a crucial role in sensing and repairing DNA DSB. MRE11 possesses dual 3'-5' exonuclease and endonuclease activity and forms the core of the multifunctional MRN complex. We previously identified a C-terminally truncated form of MRE11 (TR-MRE11) associated with post-translational MRE11 degradation. Here we identified SPRTN as the essential protease for the formation of TR-MRE11 and characterised the role of this MRE11 form in its DNA damage response (DDR). Using tandem mass spectrometry and site-directed mutagenesis, the SPRTN-dependent cleavage site for MRE11 was identified between 559 and 580 amino acids. Despite the intact interaction of TR-MRE11 with its constitutive core complex proteins RAD50 and NBS1, both nuclease activities of truncated MRE11 were dramatically reduced due to its deficient binding to DNA. Furthermore, lack of the MRE11 C-terminal decreased HR repair efficiency, very likely due to abolished recruitment of TR-MRE11 to the sites of DNA damage, which consequently led to increased cellular radiosensitivity. The presence of this DNA repair-defective TR-MRE11 could explain our previous finding that the high MRE11 protein expression by immunohistochemistry correlates with improved survival following radical radiotherapy in bladder cancer patients.
人源 MRE11/RAD50/NBS1(MRN)复合物在 DNA 双链断裂的感应和修复中发挥着关键作用。MRE11 具有双 3'-5'外切核酸酶和内切核酸酶活性,并构成多功能 MRN 复合物的核心。我们之前发现了一种与 MRE11 翻译后降解相关的 C 端截断形式的 MRE11(TR-MRE11)。在这里,我们鉴定了 SPRTN 是形成 TR-MRE11 的必需蛋白酶,并研究了这种 MRE11 形式在其 DNA 损伤反应(DDR)中的作用。通过串联质谱和定点突变,确定了 SPRTN 依赖的 MRE11 切割位点在 559 到 580 个氨基酸之间。尽管 TR-MRE11 与其组成型核心复合物蛋白 RAD50 和 NBS1 的相互作用完整,但由于其与 DNA 的结合能力不足,截断 MRE11 的两种核酸酶活性均显著降低。此外,缺乏 MRE11 C 端末端会降低 HR 修复效率,这很可能是由于 TR-MRE11 无法招募到 DNA 损伤部位,从而导致细胞对辐射的敏感性增加。这种存在缺陷的 DNA 修复 TR-MRE11 可能解释了我们之前的发现,即免疫组织化学中 MRE11 蛋白高表达与膀胱癌患者接受根治性放疗后的生存改善相关。